Harvard Bioscience Announces Reverse Stock Split
Harvard Bioscience Announces Reverse Stock Split is drawing significant interest across the industry.
Harvard Bioscience’s common stock is expected to begin trading on a post-split adjusted basis on March 16, 2026 HOLLISTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the 'Company” or 'Harvard Bioscience”), a global leader in life science research tools, today announced that its board of directors approved the Company’s 1-for-10 reverse stock split (the 'Reverse Split”) of the Company’s common stock, par value $0.01 per share. The Reverse Split was approved by the stockholders of the Company at a special meeting held on March 6, 2026.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Sufficient stock, India won't face immediate oil disruption amid Iran crisis
- What's Going On With Oracle Stock Monday?
- Stock market quote of the day by Jim Rogers | “Bottoms in the investment world don't end with four-year lows; they end with 10 or 15-year lows.”
- Nancy Pelosi, Brad Gerstner Pile Into The Same 5 Stocks - What Do They See Coming?
Source: Original →